Quantum-Si Inc Ordinary Shares - Class A QSI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
-
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
-
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
-
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
-
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
-
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
Trading Information
- Previous Close Price
- $0.96
- Day Range
- $0.88–0.95
- 52-Week Range
- $0.69–3.10
- Bid/Ask
- $0.88 / $0.88
- Shares Outstanding
- 217.76M
- Market Cap
- $192.22M
- Volume/Avg
- 33,183 / 6M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 101.67
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 145
- Website
- https://www.quantum-si.com
Valuation
|
Metric
|
QSI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.99 |
Price/Sales | 101.67 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
QSI
|
|---|---|
Quick Ratio | 11.91 |
Current Ratio | 12.60 |
Interest Coverage | — |
Quick Ratio
QSI
Profitability
|
Metric
|
QSI
|
|---|---|
Return on Assets (Normalized) | −29.08% |
Return on Equity (Normalized) | −32.20% |
Return on Invested Capital (Normalized) | −30.47% |
Return on Assets
QSI
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|b!>TKm | LOCK|LL^yg | $164B | |||
| Stryker Corp
SYK
| LOCK|?g&!?dh | LOCK|sg | $126B | |||
| Medtronic PLC
MDT
| LOCK|p%ZklN | LOCK|&Q#@& | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|>c?fX& | LOCK|>%t?t | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!n<Y%V^L | LOCK|D>ZXZ | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|yG@L<X | LOCK|QS | $29B | |||
| DexCom Inc
DXCM
| LOCK|>?D>H&B | LOCK|M@$% | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|><& | LOCK|@@C | $27B | |||
| Steris PLC
STE
| LOCK|@lX&<! | LOCK|^?lb | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|RRqMC&gZ | LOCK|Swx | $18B |
United States